1. Home
  2. SLRX
  3. SLRX News

Latest Salarius Pharmaceuticals Inc. (SLRX) News on November 25, 2025

SLRX

MT Newswires

6 days ago

Salarius Pharmaceuticals Says S&P Capital IQ Platform Misreported Nasdaq Status After Merger

SLRX

GlobeNewswire

6 days ago

Salarius Pharmaceuticals Cites Errors on S&P CapIQ Platform Following Merger with Decoy Therapeutics, Affirms Its Shares Continue to Trade on the Nasdaq Stock Market Under the Symbol “SLRX”

Ewing Sarcoma Market Research Report 2025-2035: Salarius, Eli Lilly, Pfizer, and BioAtla Lead by Driving Innovations in the Development of Novel Targeted Therapies
SLRX

GlobeNewswire

6 days ago

Ewing Sarcoma Market Research Report 2025-2035: Salarius, Eli Lilly, Pfizer, and BioAtla Lead by Driving Innovations in the Development of Novel Targeted Therapies

SLRX

Associated Press Finance

11 days ago

Salarius: Q3 Earnings Snapshot

SLRX

MT Newswires

12 days ago

Salarius Pharmaceuticals Completes Merger With Decoy Therapeutics

Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger
SLRX

GlobeNewswire

12 days ago

Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger

SLRX

Associated Press Finance

13 days ago

BC-Most Active Stocks

SLRX

MT Newswires

14 days ago

Top Midday Decliners

SLRX

MT Newswires

14 days ago

Salarius Pharmaceuticals Prices $7 Million Public Offering

Salarius Pharmaceuticals Regains Compliance with All Nasdaq Listing Requirements
SLRX

GlobeNewswire

a month ago

Salarius Pharmaceuticals Regains Compliance with All Nasdaq Listing Requirements

SLRX

Associated Press Finance

3 months ago

Salarius: Q2 Earnings Snapshot

SLRX

Associated Press Finance

6 months ago

Salarius: Q1 Earnings Snapshot

Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Appoints Renowned MIT Professor Robert S. Langer to its Scientific Advisory Board
SLRX

GlobeNewswire

7 months ago

Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Appoints Renowned MIT Professor Robert S. Langer to its Scientific Advisory Board

Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Announces its Novel Inhibitors Show Promising In Silico Activity Against Measles and Related Viruses
SLRX

GlobeNewswire

8 months ago

Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Announces its Novel Inhibitors Show Promising In Silico Activity Against Measles and Related Viruses

Salarius Pharmaceuticals Reports 2024 Financial Results and Provides Business Update
SLRX

GlobeNewswire

8 months ago

Salarius Pharmaceuticals Reports 2024 Financial Results and Provides Business Update

Salarius Pharmaceuticals Announces Patient Enrollment to Resume in Investigator-initiated Phase 1/2 Clinical Trial Using Seclidemstat with Azacitidine to Treat Hematologic Cancers
SLRX

GlobeNewswire

10 months ago

Salarius Pharmaceuticals Announces Patient Enrollment to Resume in Investigator-initiated Phase 1/2 Clinical Trial Using Seclidemstat with Azacitidine to Treat Hematologic Cancers

SLRX

MT Newswires

10 months ago

Sector Update: Health Care Stocks Rise Late Afternoon

SLRX

MT Newswires

10 months ago

Sector Update: Health Care

SLRX

MT Newswires

10 months ago

Top Midday Gainers

SLRX

MT Newswires

10 months ago

Salarius Pharma Shares More than Double on Merger Deal With Decoy Therapeutics

Salarius Pharmaceuticals and Decoy Therapeutics Announce Definitive Merger Agreement
SLRX

GlobeNewswire

10 months ago

Salarius Pharmaceuticals and Decoy Therapeutics Announce Definitive Merger Agreement

SLRX

Associated Press Finance

a year ago

Salarius: Q3 Earnings Snapshot

SLRX

Associated Press Finance

a year ago

Salarius: Q2 Earnings Snapshot

SLRX

MT Newswires

a year ago

Sector Update: Health Care Stocks Rise Late Afternoon

SLRX

MT Newswires

a year ago

Sector Update: Health Care Stocks Advance in Afternoon Trading

SLRX

MT Newswires

a year ago

Top Midday Decliners

SLRX

MT Newswires

a year ago

Salarius Pharmaceuticals Says FDA Placed Cancer Treatment Trial on Partial Hold; Shares Fall

Clinical Data on Salarius Pharmaceuticals’ Seclidemstat in Patients with MDS and CMML Presented at the 2024 European Hematology Association Annual Meeting
SLRX

GlobeNewswire

a year ago

Clinical Data on Salarius Pharmaceuticals’ Seclidemstat in Patients with MDS and CMML Presented at the 2024 European Hematology Association Annual Meeting

Salarius Pharmaceuticals Announces 1-for-8 Reverse Stock Split
SLRX

GlobeNewswire

a year ago

Salarius Pharmaceuticals Announces 1-for-8 Reverse Stock Split

Italian energy company targets Britain for fleet of 20 mini-nukes
SLRX

The Telegraph

a year ago

Italian energy company targets Britain for fleet of 20 mini-nukes

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow
SLRX

Motley Fool

a year ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Seoul resumes loudspeaker propaganda against North
SLRX

AFP

a year ago

Seoul resumes loudspeaker propaganda against North

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss
SLRX

Simply Wall St.

a year ago

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

American Software Full Year 2024 Earnings: EPS Beats Expectations
SLRX

Simply Wall St.

a year ago

American Software Full Year 2024 Earnings: EPS Beats Expectations

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns
SLRX

Simply Wall St.

a year ago

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
SLRX

Simply Wall St.

a year ago

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

3 Mistakes That Can Get Your Costco Membership Canceled
SLRX

Motley Fool

a year ago

3 Mistakes That Can Get Your Costco Membership Canceled

SLRX

Associated Press Finance

2 years ago

Salarius: Q1 Earnings Snapshot

SLRX

Zacks Small Cap Research

2 years ago

SLRX Pursues Important Goal

SLRX

Associated Press Finance

2 years ago

Salarius: Q4 Earnings Snapshot

Salarius Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
SLRX

GlobeNewswire

2 years ago

Salarius Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Salarius Provides Update on Strategic Review Process and Plans to Support Ongoing Seclidemstat Clinical Trials by Further Reducing Expenses
SLRX

GlobeNewswire

2 years ago

Salarius Provides Update on Strategic Review Process and Plans to Support Ongoing Seclidemstat Clinical Trials by Further Reducing Expenses

GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024
SLRX

GlobeNewswire

2 years ago

GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024

Castor Maritime Inc. Announces the Sales of the M/V Magic Nova and the M/V Magic Horizon for an Aggregate Price of $31.9 Million with an Aggregate Expected Net Gain of $9.0 Million
SLRX

GlobeNewswire

2 years ago

Castor Maritime Inc. Announces the Sales of the M/V Magic Nova and the M/V Magic Horizon for an Aggregate Price of $31.9 Million with an Aggregate Expected Net Gain of $9.0 Million

Here's What We Like About Peoples Bancorp of North Carolina's (NASDAQ:PEBK) Upcoming Dividend
SLRX

Simply Wall St.

2 years ago

Here's What We Like About Peoples Bancorp of North Carolina's (NASDAQ:PEBK) Upcoming Dividend

Indonesia Energy to Present at The Microcap Conference in Atlantic City on January 31 and again on February 1, 2024
SLRX

GlobeNewswire

2 years ago

Indonesia Energy to Present at The Microcap Conference in Atlantic City on January 31 and again on February 1, 2024

ElectraMeccanica and Xos Host Joint Investor Call to Provide Shareholder Update
SLRX

GlobeNewswire

2 years ago

ElectraMeccanica and Xos Host Joint Investor Call to Provide Shareholder Update

Sports Illustrated Announces Major Layoffs, Putting the Brand’s Future in Jeopardy
SLRX

The Wall Street Journal

2 years ago

Sports Illustrated Announces Major Layoffs, Putting the Brand’s Future in Jeopardy

Cohen & Company Capital Markets Highlights Strong 2023
SLRX

PR Newswire

2 years ago

Cohen & Company Capital Markets Highlights Strong 2023

Horizon Aircraft Enters into Letter of Intent to Purchase $250M of Cavorite X7 Aircraft, with an Option for up to $500M
SLRX

GlobeNewswire

2 years ago

Horizon Aircraft Enters into Letter of Intent to Purchase $250M of Cavorite X7 Aircraft, with an Option for up to $500M

Salarius Pharmaceuticals Issued U.S. Patent for Next-Generation Targeted Protein Degraders
SLRX

GlobeNewswire

2 years ago

Salarius Pharmaceuticals Issued U.S. Patent for Next-Generation Targeted Protein Degraders

40 Cities with the Lowest Life Expectancy in the US
SLRX

Insider Monkey

2 years ago

40 Cities with the Lowest Life Expectancy in the US

Investigator-initiated Phase 1/2 Clinical Trial Using Salarius Pharmaceuticals’ Seclidemstat in Combination with Azacitidine to Treat Hematologic Cancers Resumes Patient Enrollment
SLRX

GlobeNewswire

2 years ago

Investigator-initiated Phase 1/2 Clinical Trial Using Salarius Pharmaceuticals’ Seclidemstat in Combination with Azacitidine to Treat Hematologic Cancers Resumes Patient Enrollment

Save Foods: Nitrousink Commenced Controlled Trial for the Reduction of Greenhouse Gas Emissions
SLRX

GlobeNewswire

2 years ago

Save Foods: Nitrousink Commenced Controlled Trial for the Reduction of Greenhouse Gas Emissions

Biomica CEO Set to Attend JP Morgan Healthcare Week in San Francisco, January 8-11, 2024
SLRX

PR Newswire

2 years ago

Biomica CEO Set to Attend JP Morgan Healthcare Week in San Francisco, January 8-11, 2024

Eterna Therapeutics Names Sanjeev Luther as President and Chief Executive Officer
SLRX

GlobeNewswire

2 years ago

Eterna Therapeutics Names Sanjeev Luther as President and Chief Executive Officer

SLRX

Associated Press Finance

2 years ago

Emcore: Fiscal Q4 Earnings Snapshot

Science 37 Receives Top Honors in Everest PEAK Matrix®
SLRX

GlobeNewswire

2 years ago

Science 37 Receives Top Honors in Everest PEAK Matrix®

SLRX

GlobeNewswire

2 years ago

OceanPal Inc. Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2023

Trevena Awarded OLINVYK Agreement with Premier, Inc.
SLRX

GlobeNewswire

2 years ago

Trevena Awarded OLINVYK Agreement with Premier, Inc.

SLRX

PR Newswire

2 years ago

Prestige Wealth Inc. Announces First Half of Fiscal Year 2023 Financial Results

Cidara Therapeutics to Present New Preclinical Data on Novel Dual-Acting Drug-Fc Conjugates at ESMO Immuno-Oncology Annual Congress
SLRX

GlobeNewswire

2 years ago

Cidara Therapeutics to Present New Preclinical Data on Novel Dual-Acting Drug-Fc Conjugates at ESMO Immuno-Oncology Annual Congress

Interim Results from Ongoing Clinical Study Confirm EB613 Optimized Profile for Osteoporosis Treatment and Potential for Entera’s Next Generation Oral Peptide Platform
SLRX

GlobeNewswire

2 years ago

Interim Results from Ongoing Clinical Study Confirm EB613 Optimized Profile for Osteoporosis Treatment and Potential for Entera’s Next Generation Oral Peptide Platform

iClick Interactive Asia Group Limited Schedules 2023 Annual General Meeting for December 29, 2023
SLRX

PR Newswire

2 years ago

iClick Interactive Asia Group Limited Schedules 2023 Annual General Meeting for December 29, 2023

Sagimet Biosciences Announces Oral Presentation of Preclinical Results of FASN Inhibitor in Combination with Semaglutide at the 7th Obesity and NASH Drug Development Summit
SLRX

GlobeNewswire

2 years ago

Sagimet Biosciences Announces Oral Presentation of Preclinical Results of FASN Inhibitor in Combination with Semaglutide at the 7th Obesity and NASH Drug Development Summit

Onconova Therapeutics to Present at NobleCon19, Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference
SLRX

GlobeNewswire

2 years ago

Onconova Therapeutics to Present at NobleCon19, Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference

Singular Genomics Systems Founder Acquires 4.6% More Stock
SLRX

Simply Wall St.

2 years ago

Singular Genomics Systems Founder Acquires 4.6% More Stock

SLRX

Zacks Small Cap Research

2 years ago

SLRX Continues Work as it Seeks Alternatives

SLRX

Associated Press Finance

2 years ago

Salarius: Q3 Earnings Snapshot

Salarius Completes FDA Type B Meeting for Seclidemstat Ewing Sarcoma Development Program
SLRX

GlobeNewswire

2 years ago

Salarius Completes FDA Type B Meeting for Seclidemstat Ewing Sarcoma Development Program

Share on Social Networks: